Thursday, 15 October 2026European Markets

BETER BED, VALEO, Another 1 Companies Have A High Dividend Yield And Return On Equity In The Consumer Cyclical Sector.

Loading stream...

(vianews) - beter bed (bbed.as) is among this list of stock assets with the highest dividend rate and return on equity on the consumer cyclical sector.

financial asset price forward dividend yield return on equity
beter bed (bbed.as) €6.02 2.61% 23.28%
valeo (fr.pa) €17.60 2.55% 10.55%
bains mer monaco (bain.pa) €111.00 1.08% 82.87%

several euronext companies pay out dividends to its shareholders. the dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.

1. beter bed (bbed.as)

2.61% forward dividend yield and 23.28% return on equity

beter bed holding n.v. retails and wholesales bedroom furnishing products in the netherlands and belgium. the company offers beds, box springs, mattresses, bed bases, and bed textiles, as well as home delivery services. it operates retail stores under the beter bed and beddenreus brand names. the company also markets its products under the bright, beter bed basic, element, kårlsson, m-concept, m line, topcare, wave, and leazzzy brands, as well as through online platforms. beter bed holding n.v. was founded in 1981 and is headquartered in uden, the netherlands.

earnings per share

as for profitability, beter bed has a trailing twelve months eps of €0.27.

pe ratio

beter bed has a trailing twelve months price to earnings ratio of 22.3. meaning, the purchaser of the share is investing €22.3 for every euro of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 23.28%.

yearly top and bottom value

beter bed's stock is valued at €6.02 at 07:30 est, higher than its 52-week high of €5.85.

more news about beter bed.

2. valeo (fr.pa)

2.55% forward dividend yield and 10.55% return on equity

valeo se designs, produces, and sells components, systems, and services for automakers in france, other european countries, africa, north america, south america, and asia. the company operates through four segments: comfort & driving assistance systems, powertrain systems, thermal systems, and visibility systems. it offers parking and driving assistance products, such as ultrasonic sensors, radars, and cameras to detect obstacles around vehicles; intuitive control products; and a range of connectivity solutions from short-range to long-range connectivity, as well as develops systems that enable the integration of applications, such as car sharing services and remote parking systems. the company also provides powertrain systems, including electric powertrain systems for electric cars; torque converters, dual dry and wet clutches, and actuators that enable the automation of transmissions to reduce fuel consumption and enhance driving comfort; and clean engines for vehicles. in addition, it designs and manufactures systems, modules, and components to optimize thermal management of vehicles and passenger comfort in the cabin, including heating ventilation and air conditioning systems. further, the company designs and produces lighting and wiper systems for drivers in various weather conditions. additionally, it offers original equipment spares to auto manufacturers; and replacement parts and accessories to independent aftermarket for passenger cars and commercial vehicles. the company was incorporated in 1923 and is headquartered in paris, france.

earnings per share

as for profitability, valeo has a trailing twelve months eps of €0.94.

pe ratio

valeo has a trailing twelve months price to earnings ratio of 18.73. meaning, the purchaser of the share is investing €18.73 for every euro of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 10.55%.

more news about valeo.

3. bains mer monaco (bain.pa)

1.08% forward dividend yield and 82.87% return on equity

société anonyme des bains de mer et du cercle des étrangers à monaco operates in the gaming, hotels, and rental sectors in monaco. the company operates casinos; hotels; restaurants; lounge bars and nightclubs; wellness and leisure facilities; shows and concert halls; shopping centers; and meetings and events centers. it is also involved in the slot machines, table games, and other activities; and rental of residential properties, boutiques, and offices. in addition, the company offers catering services. the company was incorporated in 1863 and is headquartered in monaco.

earnings per share

as for profitability, bains mer monaco has a trailing twelve months eps of €36.56.

pe ratio

bains mer monaco has a trailing twelve months price to earnings ratio of 3.04. meaning, the purchaser of the share is investing €3.04 for every euro of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 82.87%.

dividend yield

as claimed by morningstar, inc., the next dividend payment is on oct 10, 2023, the estimated forward annual dividend rate is 1.2 and the estimated forward annual dividend yield is 1.08%.

stock price classification

according to the stochastic oscillator, a useful indicator of overbought and oversold conditions, bains mer monaco's stock is considered to be overbought (>=80).

more news about bains mer monaco.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biopharma Catalyst Cluster: Late-Stage Readouts and Regulatory Milestones
October 2026 brings a dense run of Phase 3 wins (ALOFT-IPF, RESTORE-3), new data presentations (Roche, Bayer, Lilly, Vertex, Galderma) and regulatory steps (FDA acceptance of Roche's vamikibart BLA, Scholar Rock's EMA resubmission). The next big catalyst is the ivonescimab FDA PDUFA date on 2026-11-14. Obesity combination studies (REDEFINE 4, TOGETHER-PsO) and the 2027 Maritime-1 completion point to more catalysts ahead. QAIAx's speculative AI-linked trial claims (the QIII pilot, targeted for 2027) are an unrelated micro-cap sideshow with weak evidence, and have little in common with the large-cap pipeline news.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,377 source documents archived
Query this data → isubstrate.com